Barbara Klencke
2015
In 2015, Barbara Klencke earned a total compensation of $6.2M as Chief Development Officer at ProNAi Therapeutics.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $72,752 |
| Option Awards | $5,654,031 |
| Salary | $207,863 |
| Total | $6,184,646 |
Klencke received $5.7M in option awards, accounting for 91% of the total pay in 2015.
Klencke also received $250K in bonus, $72.8K in non-equity incentive plan and $207.9K in salary.
Rankings
In 2015, Barbara Klencke's compensation ranked 1,183rd out of 13,638 executives tracked by ExecPay. In other words, Klencke earned more than 91.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,183 out of 13,638 | 91st |
Division Manufacturing | 417 out of 5,187 | 92nd |
Major group Chemicals And Allied Products | 152 out of 1,857 | 92nd |
Industry group Drugs | 116 out of 1,531 | 92nd |
Industry Pharmaceutical Preparations | 95 out of 1,179 | 92nd |
Source: SEC filing on April 25, 2017.
Klencke's colleagues
We found two more compensation records of executives who worked with Barbara Klencke at ProNAi Therapeutics in 2015.